Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 720-724

  Bigl, Marina ^a   Jandrig, Burkhard ^b   Horn, Lars Christian ^a   Eschrich, Klaus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Breast cancer; Cell line; DNA methylation; Fructose 1,6 bisphosphatase; Gene expression; Gluconeogenesis; Promoter; Tissue specific expression

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; FRUCTOSE BISPHOSPHATASE; HISTONE DEACETYLASE; ISOENZYME; MESSENGER RNA; TRICHOSTATIN A;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GENETICS; CANCER PATIENT; CELL TYPE; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; ENERGY METABOLISM; ENZYME INHIBITION; EPIGENETICS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; FRUCTOSE-BISPHOSPHATASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; HYDROXAMIC ACIDS; MIDDLE AGED; NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 55549097412     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.045     Document Type: Article

References (26)

1. el-Maghrabi M.R., Lange A.J., Jiang W., Yamagata K., Stoffel M., Takeda J., Fernald A.A., Le Beau M.M., Bell G.I., Baker L., et al. Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency. Genomics 27 (1995) 520-525
2. Herzog B., Waltner-Law M., Scott D.K., Eschrich K., and Granner D.K. Characterization of the human liver fructose-1,6-bisphosphatase gene promoter. Biochem. J. 351 Pt. 2 (2000) 385-392
3. Al-Robaiy S., and Eschrich K. Rat muscle fructose-1,6-bisphosphatase: cloning of the cDNA, expression of the recombinant enzyme, and expression analysis in different tissues. Biol. Chem. 380 (1999) 1079-1085
4. Tillmann H., and Eschrich K. Isolation and characterization of an allelic cDNA for human muscle fructose-1,6-bisphosphatase. Gene 212 (1998) 295-304
5. Tillmann H., Stein S., Liehr T., and Eschrich K. Structure and chromosomal localization of the human and mouse muscle fructose-1,6-bisphosphatase genes. Gene 247 (2000) 241-253
6. Gleeson T.T. Post-exercise lactate metabolism: a comparative review of sites, pathways, and regulation. Annu. Rev. Physiol. 58 (1996) 565-581
7. Voehringer D.W., Hirschberg D.L., Xiao J., Lu Q., Roederer M., Lock C.B., Herzenberg L.A., and Steinman H.L. Proc. Natl. Acad. Sci. USA 97 6 (2000) 2680-2685
8. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 Suppl. (2003) 245-254
9. Jin B., Seong J.K., and Ryu D.Y. Tissue-specific and de novo promoter methylation of the mouse glucose transporter 2. Biol. Pharm. Bull. 28 (2005) 2054-2057
10. Li E., Beard C., and Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 366 (1993) 362-365
11. Hannemann A., Jandrig B., Gaunitz F., Eschrich K., and Bigl M. Characterization of the human P-type 6-phosphofructo-1-kinase gene promoter in neural cell lines. Gene 345 (2005) 237-247
12. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., and Jones P.A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9 (2006) 435-443
13. Feinberg A.P., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
14. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
15. Sujatha V., and Sachdanandam P. Recuperative effect of Semecarpus anacardium linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats. Phytother. Res. 16 Suppl. 1 (2002) S14-S18
16. Zeitschel U., Schliebs R., Rossner S., Bigl V., Eschrich K., and Bigl M. Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion. J. Neurochem. 83 (2002) 371-380
17. Janke J., Schluter K., Jandrig B., Theile M., Kolble K., Arnold W., Grinstein E., Schwartz A., Estevez-Schwarz L., Schlag P.M., Jockusch B.M., and Scherneck S. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J. Exp. Med. 191 (2000) 1675-1686
18. Jandrig B., Seitz S., Hinzmann B., Arnold W., Micheel B., Koelble K., Siebert R., Schwartz A., Ruecker K., Schlag P.M., Scherneck S., and Rosenthal A. ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2. Oncogene 23 (2004) 9295-9302
19. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
20. Perumal S.S., Shanthi P., and Sachdanandam P. Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer. Cancer Chemother. Pharmacol. 56 (2005) 105-114
21. Parimala R., and Sachdanandam P. Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma. Mol. Cell. Biochem. 125 (1993) 59-63
22. De Villiers N., Burger A.P., Smith H., and Szeinfeld D. Homeostatic derangement in the CBA rodent host during the growth of the CaNT tumor. Cancer Biochem. Biophys. 13 (1993) 255-264
23. Muindi J.R., Peng Y., Wilson J.W., Johnson C.S., Branch R.A., and Trump D.L. Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients. Cancer Chemother. Pharmacol. 59 (2007) 97-104
24. Fella K., Gluckmann M., Hellmann J., Karas M., Kramer P.J., and Kroger M. Use of two-dimensional gel electrophoresis in predictive toxicology: identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 5 (2005) 1914-1927
25. Vucic E.A., Brown C.J., and Lam W.L. Epigenetics of cancer progression. Pharmacogenomics 9 (2008) 215-234
26. Han H.J., Russo J., Kohwi Y., and Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452 (2008) 187-193